Pulse nav.journalClub النقاشات النشطة الرائج استكشاف الأسئلة الباحثون

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

سياسة الخصوصية

الرئيسية استكشاف nav.journalClub الرائج

synapse

⌘+K

Pulse nav.journalClub النقاشات النشطة الرائج استكشاف الأسئلة الباحثون

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

سياسة الخصوصية

الرئيسية استكشاف nav.journalClub الرائج

synapse

⌘+K

Table S2 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity | Synapse

June 18, 2024Open Access

Table S2 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Key Points

Key points are not available for this paper at this time.

Abstract

Table S2. Top inhibitors of proteasomal ChT-like activity. Shown are the top pharmacologics that decreased proteasome ChT-like in the HTS.

Read Full Paperexternally

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Rana et al. (Tue,) studied this question.

synapsesocial.com/papers/68e64524b6db6435875d6201 https://doi.org/https://doi.org/10.1158/2767-9764.26058173.v1